Tuberculin PPD is indicated for the detection of a delayed hypersensitivity reaction to
tuberculin as an aid in the detection of infection with Mycobacterium tuberculosis.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V04CF01 | Tuberculin | V Various → V04 Diagnostic agents → V04C Other diagnostic agents → V04CF Tuberculosis diagnostics |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| TUBERCULIN Solution for injection | MPI, EU: SmPC | ||
| TUBERSOL Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old |
Tuberculin is an active ingredient of these brands:
Canada (CA)France (FR)Israel (IL)New Zealand (NZ)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
